Oncolytics Biotech Inc.
ONCY
$0.81
-$0.03-3.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.59% | -41.34% | -17.31% | 0.73% | -3.90% |
| Total Receivables | 67.71% | 1,376.80% | -26.52% | -14.70% | 31.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.37% | -9.48% | -49.25% | 78.40% | -0.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -11.55% | -- |
| Total Current Assets | 9.40% | -32.16% | -27.19% | 7.72% | 3.42% |
|
|
|||||
| Total Current Assets | 9.40% | -32.16% | -27.19% | 7.72% | 3.42% |
| Net Property, Plant & Equipment | -8.67% | 2.19% | -8.63% | -6.49% | -14.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.64% | -29.86% | -26.19% | 6.84% | 2.13% |
|
|
|||||
| Total Accounts Payable | -23.49% | 16.18% | 209.05% | 80.06% | -28.31% |
| Total Accrued Expenses | 10.70% | 8.88% | -26.28% | -0.05% | 12.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.99% | -3.31% | -6.47% | 5.75% | 0.90% |
| Total Finance Division Other Current Liabilities | -- | -46.12% | -80.15% | 95.28% | -72.79% |
| Total Other Current Liabilities | -- | -46.12% | -80.15% | 95.28% | -72.79% |
| Total Current Liabilities | -11.11% | 11.01% | 14.30% | 19.82% | -17.85% |
|
|
|||||
| Total Current Liabilities | -11.11% | 11.01% | 14.30% | 19.82% | -17.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.57% | -7.48% | -8.64% | -11.40% | -11.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.28% | 1.62% | -2.08% | 5.39% | 0.11% |
| Total Liabilities | 16.78% | 6.09% | 5.37% | 10.79% | -9.23% |
|
|
|||||
| Common Stock & APIC | 1.89% | 15.86% | -0.43% | 6.68% | -14.29% |
| Retained Earnings | -2.15% | -18.47% | -0.79% | -6.73% | 15.90% |
| Treasury Stock & Other | 0.00% | 999.05% | 7.29% | -20.80% | -89.52% |
| Total Common Equity | -35.04% | -4,699.27% | -98.15% | -1.18% | 36.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.04% | -4,699.27% | -98.15% | -1.18% | 36.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.04% | -4,699.27% | -98.15% | -1.18% | 36.99% |
|
|
|||||